LANCE: Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy

The goal of this clinical research study is to compare the outcomes of minimally invasive surgery (the investigational surgery) to laparotomy (the current standard of care) in women with Epithelial Ovarian Ccancer (EOC) who receive chemotherapy before and after surgery. Researchers want to learn if one surgery can prevent the disease from returning for longer and/or improve your quality of life after surgery. It is considered investigational to compare the outcomes of these methods when used to treat advanced EOC in women who have responded to neoadjuvant chemotherapy.

Are you Eligible? (Inclusion Criteria)

• Patients with stage 3 or 4 ovarian, fallopian tube or primary peritoneal cancer. 2. Has received 3-4 cycles of chemotherapy after and has a good response by way of CT or MRI